A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would...

Full description

Bibliographic Details
Main Authors:	Pepponi, I, Khatri, B, Tanner, R, Villarreal-Ramos, B, Vordermeier, M, McShane, H
Format:	Journal article
Published:	Elsevier 2017

Similar Items

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
by: Brennan, M, et al.
Published: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
by: Tanner, R, et al.
Published: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
by: Tanner, R, et al.
Published: (2021)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
by: Tanner, R
Published: (2015)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
by: Painter, H, et al.
Published: (2024)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
by: Tanner, R, et al.
Published: (2020)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
by: Painter, H, et al.
Published: (2024)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
by: McShane, H, et al.
Published: (2016)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
by: Mcshane, H, et al.
Published: (2017)

The humoral immune response to BCG vaccination
by: Tanner, R, et al.
Published: (2019)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
by: Tanner, R, et al.
Published: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
by: Marsay, L, et al.
Published: (2013)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
by: Tanner, R, et al.
Published: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
by: Marsay, L, et al.
Published: (2013)

Towards new TB vaccines
by: Brazier, B, et al.
Published: (2020)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
by: Tanner, R, et al.
Published: (2019)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
by: Biffar, L, et al.
Published: (2019)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
by: Painter, H, et al.
Published: (2020)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
by: Fletcher, H, et al.
Published: (2013)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
by: Dean, G, et al.
Published: (2014)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
by: Vordermeier, H, et al.
Published: (2009)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
by: O'Shea, M, et al.
Published: (2018)

TB vaccines in clinical development
by: Ginsberg, AM, et al.
Published: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
by: Vordermeier, H, et al.
Published: (2011)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
by: Dean, G, et al.
Published: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
by: Villarreal-Ramos, B, et al.
Published: (2017)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
by: Vordermeier, H, et al.
Published: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
by: Tanner, R, et al.
Published: (2021)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
by: O'Shea, M, et al.
Published: (2018)

A review of clinical models for the evaluation of human TB vaccines.
by: O'Shea, M, et al.
Published: (2016)

Progress and challenges in TB vaccine development
by: Voss, G, et al.
Published: (2018)

Glycomimetic inhibitors of mycobacterial glycosyltransferases: targeting the TB cell wall.
by: Lucas, R, et al.
Published: (2008)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
by: Villarreal-Ramos, B, et al.
Published: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
by: Villarreal-Ramos, B, et al.
Published: (2014)

Human and Bovine Tuberculosis
by: McShane, H
Published: (2016)

TB vaccines in clinical development
by: Ginsberg, A, et al.
Published: (2016)

TB vaccines in clinical development
by: Ginsburg, A, et al.
Published: (2016)

Need for more TB vaccine field sites.
by: Mcshane, H
Published: (2009)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
by: Ongarj, J, et al.
Published: (2024)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
by: McShane, H, et al.
Published: (2014)